Ostiio LLC received a $256,000 Project Grant award from the National Science Foundation on June 15, 2021 to support research and development activities concluding on May 31, 2022. The grant was awarded under the NSF's Engineering program (CFDA #47.041), which aims to improve quality of life and economic strength through engineering innovation and excellence. Specifically, the funding will support Ostiio's efforts to miniaturize a magnetic craniofacial distraction system. The company is located...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award to Reselute, Inc. provides $998,921 to develop a novel implantable orthopedic medical device and procedure to reduce recovery duration and infection risks associated with severe traumatic fractures of the long bones. The project aims to advance a 3D-printed, antibiotic-releasing intramedullary nail to improve upon current standard-of-care implants that are prone to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Magsorbeo Biomedical Corp aims to develop a bioabsorbable magnesium alloy for maxillofacial fixation. The project will demonstrate the feasibility of a custom-tailored absorption profile for this magnesium alloy implant, which could improve healing and eliminate the need for secondary removal surgeries that currently cost the U.S. healthcare system $1.72 billion...
The National Science Foundation (NSF) awarded a $275,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Orthomechanica, Inc. This SBIR Phase I grant is supporting the development of a novel implantable medical device for restoring movement and recovery during reconstructive surgery. The key objectives are to design, fabricate, and validate a prototype implant that can chronically integrate with tendons to reroute movement from a single tendon to...
The National Science Foundation (NSF) awarded a $1,000,000 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Impressio Inc., a for-profit manufacturer headquartered in Thornton, Colorado. The award supports the development, verification, validation, and commercialization of a liquid-crystal elastomer (LCE)-based cartilage replacement device to treat hallux rigidus, a joint disorder affecting the base of the big toe. The project aims to...
The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to develop an automatic debridement device from August 1, 2021 through March 31, 2022. This Small Business Innovation Research Phase I award under the Engineering (47.041) program will support the creation of a product to automatically remove dead, damaged, or infected tissue. The NSF Directorate for Engineering seeks to foster innovation and excellence in engineering research, consistent with...
This $1,000,000 Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a sustained-release, biodegradable drug delivery system using anti-inflammatory nanoparticles and Hedgehog pathway antagonists. The goal is to create a localized treatment for post-traumatic injuries and complications in orthopedic surgery that can improve patient outcomes and reduce societal costs...
The National Science Foundation (NSF) awarded a $649,810 Project Grant under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Carnegie Mellon University (CMU). The grant, with a term from February 15, 2024 to January 31, 2025, funds a convergence research project to develop flexible thin-film distributed strain sensor arrays for cochlear implants (CIs). The goal is to improve the safety and outcomes of minimally-invasive CI surgeries by enabling deformable medical...
This Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) provides $1,000,000 in funding to Winter Innovations, Inc. to develop a novel suturing device for orthopedic ligament and tendon surgical procedures. The innovation utilizes a two-part needle technology to improve surgical consistency, reduce procedure times by one-third, and decrease revision rates by nearly two-thirds compared to current...
The National Science Foundation (NSF) awarded a $979,298 Cooperative Agreement under its Technology, Innovation, and Partnerships (CFDA 47.084) program to Asante Bio LLC, a small disadvantaged business, to develop a Multi-Axial Filament Winding Process (3DMF) for biomanufacturing high-performance orthobiologic implants for rotator cuff repair. This two-year project aims to optimize the manufacturing, surgical delivery, biomechanical performance, and biocompatibility of the 3DMF implants, which...